Canon has received 510(k) clearance from the FDA for the CX-1 Hybrid Mydriatic/Non-Mydriatic Digital Retinal Camera. The device is Canon’s first fully hybrid digital retinal camera with both mydriatic and non-mydriatic modes, which may not only save time and resources but also makes the procedure more comfortable for the patient.
The CX-1 is capable of delivering clear and detailed diagnostic images for virtually immediate review. The single onboard digital camera handles five different photography modes, including non-mydriatic FAF, Color, Red-free, Cobalt and Fluorescein angiography photography.
More details from the product page:
A single push of the Myd/Non-Myd button switches between the mydriatic and non-mydriatic imaging modes.
Whether the CX-1 is in mydriatic or non-mydriatic mode, the control panel has simple operation, workflow efficiency, and ergonomic controls.
Clear, high resolution images are available in either mydriatic or non-mydriatic mode. The 2x mode magnifies the image by automatically cropping out the peripheral edges so the region of interest is larger in the frame.
The LCD monitor displays guides which automatically determine the base length for acquiring successful stereo images. The two images can be stored as a pair making it easier to manage the files.
Made exclusively for the CX-1, the detachable camera features Canon’s EOS camera technology with its renowned image processing capabilities providing optimal retinal imaging.
Product details: CX-1 Hybrid Digital Mydriatic/Non-Mydriatic Retinal Camera…
Press release: THE CANON CX-1 HYBRID MYDRIATIC/NON-MYDRIATIC DIGITAL RETINAL CAMERA RECEIVES FDA CLEARANCE…
